US Patent Litigations are now available. Check here

IP Verse

Human Monoclonal Antibodies To Programmed Death 1(Pd-1) And Methods For Treating Cancer Using Anti-Pd-1 Antibodies Alone Or In Combination With Other Immunotherapeutics

EP2439273

E R SQUIBB & SONS
Application Number
EP11178191A
Filing Date
May 2, 2006
Status
Revoked
Jul 24, 2020
Grant Date
Feb 27, 2019
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP2439273B1 was granted on Feb 27, 2019 by E R Squibb & Sons The patent is currently Revoked.

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBBNov 27, 2019ADMISSIBLE

Other Patents of E R Squibb & Sons

The table below shows the patents of E R Squibb & Sons that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3597216Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofAug 24, 20225
EP2905030Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofNov 6, 20191
EP2501822Methods For Enhanced Protein ProductionAug 16, 20172

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents